Potassium channels in the heart and blood vessels and new treatment approaches
Cardiovascular potassium channels: From molecular basis to disease therapeutics
This work looks at how certain potassium channels in the heart and blood vessels behave and how that knowledge could lead to better treatments for people with Cantu syndrome and related cardiovascular problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11252878 on NIH RePORTER |
What this research studies
From a patient's perspective, the researchers study potassium channel proteins that control electrical activity in heart and blood vessel cells using purified proteins, structural and biochemical analyses, and laboratory models. They use animal models that mimic human disease and connect specific gene changes to the signs and symptoms of Cantu syndrome. The lab also runs a specialized research clinic to link laboratory findings with people who have the condition. Together these approaches aim to turn molecular understanding of Kir and KATP channels into therapies that correct harmful overactivity.
Who could benefit from this research
Good fit: People with genetically confirmed or suspected Cantu syndrome or with clinical features linked to KATP/Kir channel dysfunction (for example enlarged heart, low vascular resistance, pericardial effusion, lymphedema, or gut motility problems) would be the best candidates to engage.
Not a fit: Patients whose heart or vascular problems are caused by mechanisms unrelated to potassium channel dysfunction are unlikely to receive direct benefit from this work.
Why it matters
Potential benefit: If successful, this work could lead to treatments that correct overactive KATP potassium channels and reduce heart and vascular complications in people with Cantu syndrome.
How similar studies have performed: Previous work from this group and others has already linked KATP channel mutations to Cantu syndrome and suggests that targeting these channels is promising, though therapeutic translation is still developing.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Nichols, Colin G — Washington University
- Study coordinator: Nichols, Colin G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.